Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Harkes

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Nature|September 4, 2024
Mechanisms that clear mutations drive field cancerization in mammary tissueMarta Ciwinska, Hendrik A Messal, Hristina R Hristova, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 20, 2024
A novel lineage-tracing tool reveals that hypoxic tumor cells drive tumor relapse after radiotherapyApostolos Menegakis, Claire Vennin, Jonathan Ient, et al.
NPJ Breast Cancer|October 21, 2021
IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal womenStacey E P Joosten, Marius Wellenstein, Rutger Koornstra, et al.
Nature Genetics|July 4, 2025
Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancersTim Arnoldus, Alex van Vliet, Onno B Bleijerveld, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2025
Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trialChantal F Stockem, Jeroen van Dorp, Nick van Dijk, et al.
Nature|November 19, 2025
Tumour-reactive heterotypic CD8 T cell clusters from clinical samplesSofía Ibáñez-Molero, Johanna Veldman, Juan Simon Nieto, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Nature|September 4, 2024
Mechanisms that clear mutations drive field cancerization in mammary tissueMarta Ciwinska, Hendrik A Messal, Hristina R Hristova, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 20, 2024
A novel lineage-tracing tool reveals that hypoxic tumor cells drive tumor relapse after radiotherapyApostolos Menegakis, Claire Vennin, Jonathan Ient, et al.
NPJ Breast Cancer|October 21, 2021
IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal womenStacey E P Joosten, Marius Wellenstein, Rutger Koornstra, et al.
Nature Genetics|July 4, 2025
Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancersTim Arnoldus, Alex van Vliet, Onno B Bleijerveld, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2025
Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trialChantal F Stockem, Jeroen van Dorp, Nick van Dijk, et al.
Nature|November 19, 2025
Tumour-reactive heterotypic CD8 T cell clusters from clinical samplesSofía Ibáñez-Molero, Johanna Veldman, Juan Simon Nieto, et al.
Pageof 2